Bio-Key International (BKYI)
OTHER OTC:BKYI
Want to see BKYI full AI Analyst Report?
Earnings Data
Report Date
Aug 17, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.8Last Year’s EPS
-2Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed meaningful operational and financial progress: strong top-line growth (+34%), higher-margin license expansion (+24%), a >100% rise in hardware revenue, a 33% increase in gross profit and a large reduction in net loss (≈77.6%). Management highlighted expanding global partnerships (notably TD Synnex/DLT), an improving pipeline with larger deals, and guidance toward profitability and positive cash flow in Q2. Key risks discussed include a recent NASDAQ suspension (appeal pending), prior delinquent filings that management is remediating, a quarter-over-quarter cash decline, and some lumpy/one-time inventory-driven hardware sales. On balance, the positives (growth, margins, partnerships, improved profitability outlook) significantly outweigh the operational and listing-related negatives.Company Guidance
Revenue Growth
Total Q1 2026 revenues increased 34% year-over-year to $2.1 million (vs. $1.6M in Q1 2025).
License Fee Expansion
License fee revenue rose 24% year-over-year to $1.4 million, driven in part by a 1-year software license renewal from a long-time banking customer serving ~30 million clients.
Hardware Revenue Surge
Hardware revenue increased by more than 100% to approximately $531,000, supported by increased hardware purchases (including a foreign Defense Ministry) and sales of previously fully reserved inventory.
Improved Gross Profit and Strong Margins
Q1 gross profit grew ~33% year-over-year and the company maintained a high gross margin of 82% (consistent with the period), benefiting from higher-margin license revenue and reserved inventory sales.
Substantial Net Loss Improvement
Net loss improved materially from $736,545 in Q1 2025 to $165,036 in Q1 2026 (per share: reduced from $1.57 to $0.15), representing approximately a 77.6% reduction in net loss year-over-year.
Solid Balance Sheet and Liquidity
Book value at 03/31/26 was $7.6 million (~$7.04 per share) with approximately $2.2 million in cash and cash equivalents and $1.6 million in accounts receivable; current assets totaled ~$4.5 million.
Partnerships and Distribution Expansion
Signed strategic partnership with DLT Solutions (TD Synnex public sector arm) to integrate PortalGuard IAM and Passkey:YOU, opening a streamlined procurement path into U.S. public sector; expanded partner footprint in EMEA, India and Vietnam.
Recurring / Channel-Driven Business Model
Business is predominantly subscription-based and recurring; approximately 50% of new domestic business comes through partners and 100% of international business is sold through channel partners, supporting a scalable go-to-market model.
Operational Momentum and Outlook
Management reports stronger pipeline with larger deal sizes, expects profitability and positive cash flow in Q2 2026, and expresses confidence in scaling revenue toward multi-million-dollar quarterly levels.
Corporate Governance & Reporting Progress
Company expects to file the 2025 Form 10-K this week and then file the 10-Q to become up-to-date on SEC filings; independent review of Q1 results is pending and subject to adjustments.
BKYI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BKYI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 18, 2026 | $4.25 | $4.27 | +0.49% |
Mar 31, 2026 | $5.98 | $5.30 | -11.37% |
Nov 14, 2025 | $9.70 | $9.47 | -2.37% |
Aug 13, 2025 | $8.08 | $7.92 | -2.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bio-Key International (BKYI) report earnings?
Bio-Key International (BKYI) is schdueled to report earning on Aug 17, 2026, Before Open (Confirmed).
What is Bio-Key International (BKYI) earnings time?
Bio-Key International (BKYI) earnings time is at Aug 17, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BKYI EPS forecast?
BKYI EPS forecast for the fiscal quarter 2026 (Q2) is -0.8.